Begin main content

Calls for Patient Input: Iluvien and Probuphine

Published on: November 22, 2017
Result type: News

CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.

Iluvien

Brand name Generic name Manufacturer Indication(s)
Iluvien fluocinolone acetate Knight Therapeutics Inc. Diabetic macular edema (DME)
Project Number Call for patient input Patient input deadline Submit patient input
SR0549-000 2017-11-22 2018-01-18 Submit

Probuphine

Brand name Generic name Manufacturer Indication(s)
Probuphine buprenorphine hydrochloride Knight Therapeutics Inc. Opioid drug dependence, treatment
Project Number Call for patient input Patient input deadline Submit patient input
SR0550-000 2017-11-22 2018-01-18 Submit